Susanne Krämer

1.6k total citations
42 papers, 1.1k citations indexed

About

Susanne Krämer is a scholar working on Molecular Biology, Cell Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Susanne Krämer has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Cell Biology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Susanne Krämer's work include Skin and Cellular Biology Research (15 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Peptidase Inhibition and Analysis (8 papers). Susanne Krämer is often cited by papers focused on Skin and Cellular Biology Research (15 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Peptidase Inhibition and Analysis (8 papers). Susanne Krämer collaborates with scholars based in Germany, Chile and Spain. Susanne Krämer's co-authors include Walter Mier, Uwe Haberkorn, Annette Altmann, Michael Eisenhut, Machiko Ikegami, Alan H. Jobe, Boris W. Kramer, Sabine Zitzmann, Jürgen Debus and Vasileios Askoxylakis and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Susanne Krämer

40 papers receiving 1.1k citations

Peers

Countries citing papers authored by Susanne Krämer

Since Specialization

Citations

This map shows the geographic impact of Susanne Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Krämer more than expected).

Fields of papers citing papers by Susanne Krämer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Krämer. The network helps show where Susanne Krämer may publish in the future.

Co-authorship network of co-authors of Susanne Krämer

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Krämer. A scholar is included among the top collaborators of Susanne Krämer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Krämer. Susanne Krämer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence of Crown Resorption in Amelogenesis Imperfecta due to Junctional Epidermolysis Bullosa 2025 ·Oral Diseases ·(unknown), (unknown), (unknown), Marco Cornejo‐Ovalle, Ignacia Fuentes, Francis Palisson, Susanne Krämer	1
2	Orthodontic Treatment in Patients With Epidermolysis Bullosa (EB)—Clinical Practice Guidelines (CPG) 2025 ·Special Care in Dentistry ·(unknown), (unknown), María Serrano, Carole Charavet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anna Verdonck, Anne W. Lucky, Cristina Has, (unknown), Susanne Krämer	1
3	Oral health of individuals with intellectual disabilities: a global cross-sectional study from the special olympics world games 2023 2025 ·Clinical Oral Investigations ·(unknown), Susanne Krämer, Peter R. Schmidt, A. Schulte, (unknown), Falk Schwendicke, Luc Marks, Benedikt C. Spies, (unknown)	0
4	Oral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseases 2024 ·Journal of the European Academy of Dermatology and Venereology ·Susanne Krämer, (unknown), Katrin Bekes, Katharina Bücher, (unknown), Hady Haririan, (unknown), (unknown), (unknown), (unknown), Stephen Porter, Reinhard Schilke, (unknown), (unknown), (unknown), Maria C. Bolling, Anja Diem, Jemima E. Mellerio, Christine Bodemer, Cristina Has	1
5	Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with²¹³Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors 2024 ·Journal of Nuclear Medicine ·Andreas Helisch, Clemens Kratochwil, Christian Kleist, Susanne Krämer, Josefa Castillo, Katharina Dendl, Hendrik Rathke, (unknown), Mathias Schreckenberger, Dirk Jäger, Thomas Lindner, Walter Mier, (unknown), Uwe Haberkorn, Manuel Röhrich	1
6	Mini‐implant assisted palate expansion and digital design in junctional epidermolysis bullosa and amelogenesis imperfecta: Case report 2024 ·Special Care in Dentistry ·(unknown), (unknown), Susanne Krämer	2
7	Absence of tongue papillae as a clinical criterion for the diagnosis of generalized recessive dystrophic epidermolysis bullosa types 2020 ·Journal of the American Academy of Dermatology ·Susanne Krämer, Ignacia Fuentes, (unknown), (unknown), (unknown), Ignacio Araya, J. Bennett, (unknown), (unknown), (unknown), (unknown), Anne W. Lucky, Francis Palisson	3
8	Design and Development of ^99mTc-Labeled FAPI Tracers for SPECT Imaging and ¹⁸⁸Re Therapy 2020 ·Journal of Nuclear Medicine ·Thomas Lindner, Annette Altmann, Susanne Krämer, Christian Kleist, Anastasia Loktev, Clemens Kratochwil, Frederik L. Giesel, Walter Mier, Frederik Marmé, Jürgen Debus, Uwe Haberkorn	138
9	Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model 2016 ·Cancer Letters ·Tobias Weber, (unknown), Michaela A.E. Arndt, Walter Mier, Max Sauter, (unknown), Armin Keller, Susanne Krämer, Karin Leotta, (unknown), Ludger Große‐Hovest, Dirk Strumberg, Dirk Jäger, Hermann-Josef Gröne, Uwe Haberkorn, Г. Брем, Jürgen Krauß	3
10	De Novo COL7A1 mutation in a patient with trisomy 21: coexistence of dystrophic epidermolysis bullosa and Down syndrome 2012 ·International Journal of Dermatology ·(unknown), Fernándo Rodríguez, (unknown), Francis Palisson, (unknown), Susanne Krämer, Gabriela M. Repetto	3
11	Oral Health Care for Patients with Epidermolysis Bullosa ‐ Best Clinical Practice Guidelines 2012 ·International Journal of Paediatric Dentistry ·Susanne Krämer, María Serrano, (unknown), (unknown), Ignacio Araya, Nicolás Yanine, Alonso Carrasco‐Labra, Patricio Oliva, Romina Brignardello‐Petersen, Julio Villanueva	52
12	Binding of the Phage Display Derived Peptide CaIX-P1 on Human Colorectal Carcinoma Cells Correlates with the Expression of Carbonic Anhydrase IX 2012 ·International Journal of Molecular Sciences ·Vasileios Askoxylakis, Volker Ehemann, (unknown), Susanne Krämer, Nuh N. Rahbari, Jürgen Debus, Uwe Haberkorn	9
13	Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa 2010 ·Cytotherapy ·Paulette Conget, Fernándo Rodríguez, Susanne Krämer, Carolina Allers, Valeska Simon, Francis Palisson, Sergio González, (unknown)	150
14	Oral Care and Dental Management for Patients with Epidermolysis Bullosa 2010 ·Dermatologic Clinics ·Susanne Krämer	25
15	A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology 2010 ·PLoS ONE ·Vasileios Askoxylakis, (unknown), (unknown), Susanne Krämer, Ulrike Hebling, Walter Mier, Annette Altmann, Annette Markert, Jürgen Debus, Uwe Haberkorn	28
16	Identification and Characterization of a Peptide with Affinity to Head and Neck Cancer 2009 ·Journal of Nuclear Medicine ·(unknown), Sabine Zitzmann-Kolbe, (unknown), Susanne Krämer, Christel Herold‐Mende, Annette Altmann, Michael Eisenhut, Walter Mier, Uwe Haberkorn	37
17	Influence of Chelate Conjugation on a Newly Identified Tumor-Targeting Peptide 2007 ·Journal of Nuclear Medicine ·Walter Mier, Sabine Zitzmann, Susanne Krämer, J. Reed, (unknown), Annette Altmann, Michael Eisenhut, Uwe Haberkorn	16
18	Identification and Evaluation of a New Tumor Cell-Binding Peptide, FROP-1 2007 ·Journal of Nuclear Medicine ·Sabine Zitzmann, Susanne Krämer, Walter Mier, Ulrike Hebling, Annette Altmann, (unknown), Dietmar Berndorff, Michael Eisenhut, Uwe Haberkorn	30
19	Conjugation of DOTA Using Isolated Phenolic Active Esters: The Labeling and Biodistribution of Albumin as Blood Pool Marker 2004 ·Bioconjugate Chemistry ·Walter Mier, Johannes Hoffend, Susanne Krämer, Jochen Schuhmacher, William E. Hull, Michael Eisenhut, Uwe Haberkorn	53
20	Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters. 1991 ·PubMed ·Joel Lundy, Allan Schuss, (unknown), (unknown), Susanne Krämer, J Sorvillo	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact